← Eichor
Study identifier: NCT03232918 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Oxytocin and Fetal Heart Rate Changes

Condition: Fetal Bradycardia Complicating Labor and Delivery · Fetal Bradycardia During Labor · Fetal Heart Rate or Rhythm Abnormality Affecting Fetus  ·  Sponsor: Unyime Ituk

PhasePhase 4
Planned participants730
Who can joinFemale, 18 Years to 55 Years
Healthy volunteersYes

About this study

The reported risk of nonreassuring fetal heart trace following neuraxial analgesia is 3-23%. This variability may be due to fluid and oxytocin management prior to and during the initiation of neuraxial analgesia. The study hypothesis is that decreasing the oxytocin infusion rate by 50 % prior to initiation of combined spinal epidural analgesia will cause a reduction in the incidence of adverse fetal heart rate changes.

This description comes directly from the study's public registry record.

Talk to the study team

Unyime Ituk  ·  319-356-2633  ·  unyime-ituk@uiowa.edu

Always discuss trial participation with your own doctor first.

Locations (2)

University of Iowa Hospitals and ClinicsIowa City, Iowa, United StatesRecruiting
Medical College of WisconsinMilwaukee, Wisconsin, United StatesNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03232918